The investment firm is acquiring Mitsubishi Tanabe Pharma in a deal valued at $3.3 billion. Elsewhere, Bausch + Lomb hasn’t ...
(Reuters) -Bausch + Lomb will not be taken private at this time, the contact lens maker said on Thursday, sending its ...
Bausch Health Companies Inc.’s years-long process of trying to separate its Bausch + Lomb Corp. eye-care business hit a roadblock Thursday when a potential sale to private equity fell through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback